The national development environment and infrastructure of Trinitas DX will provide targeted support to carefully selected projects and entrepreneurs, with the aim of fully exploiting the diagnostics market. By reducing risks and optimizing market opportunities, Trinitas DX will contribute to a better experience for patients, healthcare cost savings, reduction of work pressure in healthcare, and the creation of new jobs in healthcare and business.
Trinitas DX offers investors and entrepreneurs the opportunity to participate in an innovative and promising initiative that will not only have a societal impact but also stimulate economic growth and opportunities for academic entrepreneurship.
The founders of Trinitas DX are Amsterdam UMC, UMC Utrecht, Sanquin, and Leiden University in collaboration with the Consortium for Research in General Practice (COH). Additionally, LUMC, Maastricht UMC+ (via Maastricht University), Radboudumc, and Groningen UMC have committed to this initiative. There is also collaboration with STZ hospitals. The consortium consists of a broad and diverse group of experts and advisors, including healthcare providers and scientists.
The business sector is involved through more than 35 national and international entrepreneurs (85% Dutch and 15% global companies) with whom project plans for the launch of Trinitas DX have been developed.
